Compara mètodes

	Qüestionari de Consciència d'Hipoglucèmia de Clarke	ThyPRO: Escala d'Hasil Reportat pels Pacients Relacionat amb la Tiroide
Camp	Endocrinologia	Endocrinologia
Família	Process / pipeline	Process / pipeline
Any d'origen	1995	2009
Autor original	William L. Clarke, Don J. Cox, Lois A. Gonder-Frederick	Torquil Watt, Jens Bjørner, Marianne Groenvold
Tipus	Patient self-report questionnaire	Patient self-report questionnaire
Font seminal	Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995). Reduced awareness of hypoglycemia in adults with IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care, 18(6), 517-522.	Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580.
Àlies	HAQ, Clarke HAQ, Hypoglycemia Awareness Scale	ThyPRO-85, ThyPRO-39
Relacionats	3	3
Resum	The Clarke Hypoglycemia Awareness Questionnaire is an 8-item instrument designed to identify patients with impaired hypoglycemia awareness—a condition in which diabetic patients fail to perceive early warning symptoms of low blood glucose, substantially increasing their risk of severe hypoglycemia. Developed by Clarke and colleagues in 1995, it is the most widely used screening tool for this dangerous complication in type 1 diabetes and in insulin-treated type 2 diabetes populations.	ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer.